📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus. (2019)

First Author: Fawsitt CG

Attributed to: In-depth structural characterization of the tetraspanin CD81 funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2018.12.011

PubMed Identifier: 31198187

Publication URI: http://europepmc.org/abstract/MED/31198187

Type: Journal Article/Review

Volume: 22

Parent Publication: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Issue: 6

ISSN: 1098-3015